Skip to main content
Log in

Sleepiness as a marker of glucose deregulation in obstructive sleep apnea

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Background

Excessive daytime sleepiness (EDS) is a major but not universally present feature of obstructive sleep apnea syndrome (OSAS). The latter has been associated with glucose dysmetabolism and insulin resistance. The aim of this study was to examine the role of EDS by investigating potential differences between somnolent and non-somnolent OSAS patients in glucose metabolism, insulin resistance, and levels of cardiovascular risk factors.

Methods

Included were 25 newly diagnosed otherwise healthy OSAS patients, reporting EDS (ESS ≥ 11) and 25 age- and BMI-matched, non-somnolent (ESS ≤ 10) OSAS patients, who served as controls. Fasting glucose and insulin levels, as well as homeostatic model assessment of insulin resistance (HOMAIR) index, levels of hs-CRP, and lipidemic profile were measured.

Results

The two groups did not differ in anthropometric or sleep characteristics. A significant correlation of ESS with glucose (p = 0.004), insulin (p = 0.011), and HOMAIR (p = 0.031) was observed. Somnolent patients had higher levels of glucose (p = 0.045), insulin (p = 0.012), and HOMAIR (p = 0.027). No difference was detected in other markers between the two groups.

Conclusions

Daytime sleepiness in OSAS patients is associated with hyperglycemia and hyperinsulinemia. These results suggest its potential use as a surrogate marker of insulin resistance in such patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136–143

    Article  PubMed  Google Scholar 

  2. McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156–178

    Article  PubMed  CAS  Google Scholar 

  3. Lévy P, Bonsignore MR, Eckel J (2009) Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34:243–260

    Article  PubMed  Google Scholar 

  4. Steiropoulos P, Papanas N, Nena E, Antoniadou M, Serasli E, Papoti S, Hatzizisi O, Kyriazis G, Tzouvelekis A, Maltezos E, Tsara V, Bouros D (2010) Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediat Inflamm 2010:675320

    Article  Google Scholar 

  5. Steiropoulos P, Papanas N, Nena E, Maltezos E, Bouros D (2010) Continuous positive airway pressure treatment in patients with sleep apnoea: does it really improve glucose metabolism? Curr Diabetes Rev 6:156–166

    Article  PubMed  Google Scholar 

  6. Mediano O, Barceló A, de la Peña M, Gozal D, Agustí A, Barbé F (2007) Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 30:110–113

    Article  PubMed  CAS  Google Scholar 

  7. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90:4510–4515

    Article  PubMed  CAS  Google Scholar 

  8. Lindberg E, Berne C, Franklin KA, Svensson M, Janson C (2007) Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women—a population-based study. Respir Med 101:1283–1290

    Article  PubMed  Google Scholar 

  9. Montserrat JM, Garcia-Rio F, Barbe F (2007) Diagnostic and therapeutic approach to nonsleepy apnea. Am J Respir Crit Care Med 176:6–9

    Article  PubMed  Google Scholar 

  10. Barbé F, Mayoralas LR, Masa DJ, JF MA, Montserrat JM, Monasterio C, Bosch M, Ladaria A, Rubio M, Rubio R, Medinas M, Hernandez L, Vidal S, Douglas NJ, Agustí AG (2001) Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness, a randomized, controlled trial. Ann Intern Med 134:1015–1023

    PubMed  Google Scholar 

  11. Robinson GV, Langford BA, Smith DM, Stradling JR (2008) Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax 63:855–859

    Article  PubMed  CAS  Google Scholar 

  12. Barceló A, Barbé F, de la Peña M, Martinez P, Soriano JB, Piérola J, Agustí AG (2008) Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 63:946–950

    Article  PubMed  Google Scholar 

  13. Nena E, Steiropoulos P, Constantinidis TC, Perantoni E, Tsara V (2010) Work productivity in obstructive sleep apnea patients. J Occup Environ Med 52:622–625

    Article  PubMed  Google Scholar 

  14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Diab Care 20:1183–1197

    Google Scholar 

  15. Tsara V, Serasli E, Amfilochiou A, Constantinidis T, Christaki P (2004) Greek version of the Epworth Sleepiness Scale. Sleep Breath 8:91–95

    Article  PubMed  Google Scholar 

  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  17. Saaresranta T, Irjala K, Aittokallio T, Polo O (2005) Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease. Respir Med 99:856–863

    Article  PubMed  Google Scholar 

  18. Ronksley PE, Hemmelgarn BR, Heitman SJ, Hanly PJ, Faris PD, Quan H, Tsai WH (2009) Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 64:834–839

    Article  PubMed  CAS  Google Scholar 

  19. Polotsky VY, Rubin AE, Balbir A, Dean T, Smith PL, Schwartz AR, O'Donnell CP (2006) Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med 7:7–16

    Article  PubMed  Google Scholar 

  20. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, Gow A (2004) Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep–wake brain regions. Sleep 27:194–201

    PubMed  Google Scholar 

  21. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    PubMed  Google Scholar 

  22. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE, Sleep Heart Health Study Investigators (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530

    Article  PubMed  Google Scholar 

  23. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell CP (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253–264

    Article  PubMed  CAS  Google Scholar 

  24. Liyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175:851–857

    Article  Google Scholar 

  25. Vgontzas AN, Bixler EO, Chrousos GP (2006) Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann NY Acad Sci 1083:329–344

    Article  PubMed  CAS  Google Scholar 

  26. Ip MS (2008) Obstructive sleep apnoea, insulin resistance and sleepiness. Thorax 63:939–940

    Article  PubMed  Google Scholar 

  27. Nonogaki K (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43(5):533–549

    Article  PubMed  CAS  Google Scholar 

  28. Stamatakis KA, Punjabi NM (2010) Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 137:95–101

    Article  PubMed  CAS  Google Scholar 

  29. Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 29:5–11

    Article  Google Scholar 

  30. Vaughn BV, Giallanza P (2008) Technical review of polysomnography. Chest 134:1310–1319

    Article  PubMed  Google Scholar 

  31. Unwin N, Gan D, Whiting D (2010) The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 87:2–3

    Article  PubMed  Google Scholar 

  32. Thurnheer R (2007) Obstructive sleep apnea and cardiovascular disease—time to act! Swiss Med Wkly 137:217–222

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evangelia Nena.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nena, E., Steiropoulos, P., Papanas, N. et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath 16, 181–186 (2012). https://doi.org/10.1007/s11325-010-0472-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-010-0472-y

Keywords

Navigation